REPOZYTORIUM UNIWERSYTETU
W BIAŁYMSTOKU
UwB

  1. Repozytorium Uniwersytetu w Białymstoku
  2. Wydawnictwa
  3. Wydawnictwo Uniwersytetu w Białymstoku
  4. Książki / Rozdziały (WUwB)

Szukanie zaawansowane
  • Zespoły i Kolekcje


  • Zaloguj się
  • Zarejestruj się
  • Mój RUB
  • FAQ
  • Polityka
  • Regulamin
  • DOI
  • Instrukcja
  • Aspekty prawne
  • Open Access
  • Archiwum


  • Kontakt
  • O Dspace
  • Strona Biblioteki
  • Strona Uczelni



    • Proszę używać tego identyfikatora do cytowań lub wstaw link do tej pozycji: http://hdl.handle.net/11320/16026
    Pełny rekord metadanych
    Pole DCWartośćJęzyk
    dc.contributor.authorSiemieniuk, Magdalena-
    dc.contributor.authorGrabowska, E.-
    dc.contributor.authorCzyżewska, Urszula-
    dc.contributor.authorBartoszewicz, Marek-
    dc.contributor.authorTylicki, Adam-
    dc.date.accessioned2024-02-09T13:20:38Z-
    dc.date.available2024-02-09T13:20:38Z-
    dc.date.issued2019-
    dc.identifier.citationModern problems and solutions in environmental protection. Post-conference monograph of Current Environmental Issues 2019, edited by by Joanna Karpińska, Marek Bartoszewicz, Róża Sawczuk, Białystok 2019, s. 146-156pl
    dc.identifier.isbn978-83-7431-615-6-
    dc.identifier.urihttp://hdl.handle.net/11320/16026-
    dc.descriptionZdigitalizowano i udostępniono w ramach projektu pn. Rozbudowa otwartych zasobów naukowych Repozytorium Uniwersytetu w Białymstoku – kontynuacja, dofinansowanego z programu „Społeczna odpowiedzialność nauki” Ministra Edukacji i Nauki na podstawie umowy BIBL/SP/0040/2023/01.pl
    dc.description.abstractPolyenes are one of the most commonly used drugs in the treatment of mycoses. In the polyenes group we can find amphotericin B, nystatin, and natamycin. The resistance of pathogenic fungi is rare, but more visible than a few years ago. Several mechanisms of resistance have been described, concerning ergosterol in cell membrane, biofilm formation, and others. The aim of this paper was to describe the polyenes and try to explain mechanisms which may lead to resistance of fungi.pl
    dc.language.isoenpl
    dc.publisherUniversity of Bialystok Presspl
    dc.subjectantibioticspl
    dc.subjectpathogenic fungipl
    dc.subjectfungemiapl
    dc.subjectsuperficial mycosespl
    dc.titlePolyenes in therapy of mycosis - characteristics and mechanism of resistancepl
    dc.typeBook chapterpl
    dc.rights.holder© Copyright by Uniwersytet w Białymstoku, Białystok 2019pl
    dc.description.AffiliationMagdalena Siemieniuk - Department of Cytobiochemistry, Faculty of Biology, University of Bialystokpl
    dc.description.AffiliationE. Grabowska - Department of Cytobiochemistry, Faculty of Biology, University of Bialystokpl
    dc.description.AffiliationUrszula Czyżewska - Department of Cytobiochemistry, Faculty of Biology, University of Bialystokpl
    dc.description.AffiliationMarek Bartoszewicz - Department of Microbiology, Faculty of Biology, University of Bialystokpl
    dc.description.AffiliationAdam Tylicki - Department of Cytobiochemistry, Faculty of Biology, University of Bialystokpl
    dc.description.referencesBongomin F. Gago S., Oladele R., Denning D. (2017) Global and multi-national prevalence of fungal diseases-estimate precision. Journal of Fungi, 3:57.pl
    dc.description.referencesDesai V.C.A.,Cavanaugh T.M.,Kelton C.M.L., Guo J.J., Heaton P.C. (2012) Trends in the Utilization of Spending on and Prices for Outpatient Antifungal Agents in US Medicaid Programs: 1991-2009. Clinical Therapeutics, 34: 2118-2131.pl
    dc.description.referencesStaniszewska M., Bondaryk M., Kowalska M., Magda U., Luka M., Ochal Z., Kurzątkowski W. (2014) Patogeneza i leczenie zakażeń Candida spp. Postępy Mikrobiologii, 53: 229 - 240.pl
    dc.description.referencesNett J.E., Andes D.R (2015) Antifungal Agents: Spectrum of Activity, Pharmacology, and Clinical Indications. Infectious Disease Clinics of North America, 30: 51 - 83.pl
    dc.description.referencesBondaryk M., Kurzątkowski W., Staniszewska M. (20l3) Antifungal agents commonly used in the superficial and mucosal candidiasis treatment: mode of action and resistance development. Postępy Dermatologii i Alergologii, 5: 293 - 301.pl
    dc.description.referencesSzymańska M., Baranowski A. Płachta D. (2007) Przegląd preparatów najczęściej stosowanych w leczeniu chorób grzybiczych. Biuletyn Wydziału Farmaceutycznego AMW, 1: 1 - 12.pl
    dc.description.referencesZiółkowska G., Tokarzewski S. (2007) Aktualne problemy w leczeniu i profilaktyce infekcji grzybiczych u ptaków. Annales UMCS Section DD 62: 71 - 79.pl
    dc.description.referencesCampoy S., Adrio J. L. (2017) Antifungals. Biochemical Pharmacology, 133: 86 - 96.pl
    dc.description.referencesEllis D. (2002) Amphotericin B: spectrum and resistance. Journal of Antimicrobial Chemotherapy, 49: 7 - 10.pl
    dc.description.referencesGhannoum M.A., Rice L.B. (1999) Antifungal Agents: Mode of Action, mechanisms of resistance and correlation of these mechanisms with bacterial resistance. Clinical Microbiology Reviews, 12: 501 - 517.pl
    dc.description.referencesOstrosky-Zeichner L., Marr K.A., Rex J.H., Cohen S. H. (2003) Amphotericin B: time for a new" gold standard". Clinical Infectious Diseases, 37: 415 - 425.pl
    dc.description.referencesLiu M., Chen M., Yang Z. (2017) Design of amphotericin B oral formulation for antifungal therapy. Drug Delivery, 24: 1-9.pl
    dc.description.referencesMaleszka R., Adamski Z. (2001) Leki przeciwgrzybicze w codziennej praktyce lekarskiej. Przewodnik Lekarza, 4: 48 - 56.pl
    dc.description.referencesBiliński P., Seferyńska I.,Warzocha K. (2008) Diagnostyka i leczenie układowych zakażeń grzybiczych w onkohematologii. Onkologia w Praktyce Klinicznej, 4: 15-24.pl
    dc.description.referencesPaczkowska I., Wójtowicz A., Malm A. (2010) Wybrane aspekty farmakoterapii kandydoz. Terapia i Leki, 66: 539-543.pl
    dc.description.referencesMaleszka R., Adamski Z., Szepietowski J., Baran E. (2015) Leczenie powierzchownych zakażeń grzybiczych-rekomendacje ekspertów Sekcji Mikologicznej Polskiego Towarzystwa Dermatologicznego. Przeglad Dermatologiczny, 102.pl
    dc.description.referencesShi S., Tao Y., Liu, W. (2017) Effects of Fungi Fermentation Broth on Natamycin Production of Streptomyces.pl
    dc.description.referencesDalhoff A.A., Levy S.B. (2015) Does use of the polyene natamycin as a food preservative jeopardise the clinical efficacy of amphotericin B? A word of concern. International jomnal of antimicrobial agents, 45: 564 - 567.pl
    dc.description.referencesKrishnasamy L., Krishnakumar S., Kumaramanickavel G., Saikumar C. (2018) Molecular Mechanisms of Antifungal Drug Resistance in Candida Species. Journal of Clinical and Diagnostic Research, 12(6): 1-6.pl
    dc.description.referencesSanglard D. (2016) Emerging Threats in Antifungal-Resistant Fungal Pathogens. Frontiers in Medicine, 3, 11: 1-10.pl
    dc.description.referencesWhite T. C., Marr K.A., Bowden R.A. (1998) Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance. Clinical Microbiology Reviews, 11, 2: 382-402.pl
    dc.description.referencesMorio F., Jensen R. H., Le Pape P., Arendrup M. C. (2017) Molecular basis of antifungal drug resistance in yeasts. International Journal of Antimicrobial Agents, 50, 5: 599-606.pl
    dc.description.referencesO'Shaughnessy E., Lyman C.A., Walsh T. J. (2009) Amphotericin B: Polyene Resistance Mechanisms. Antimicrobial Drug Resistance: Mechaninisms of Drug Resistance, 295-305, DOI 10.1007/978-1-59745-180-2_25.pl
    dc.description.referencesPerlin D. S., Rautemaa-Richardson R., Alastruey-Izquierdo A (2017) The global problem of antifungal resistance: prevalence, machanisms, and management. The Lancet Infectious Diseases, 17, 12: 1-10.pl
    dc.description.referencesVandeputte P., Trochin G., Larcher G. et al. (2008) A Nonsense Mutation in the ERG6 Gene Leads to Reduced Susceptibility to Polyenes in a Clinical Isolate of Candida glabrata. Antimicrob Agents Chemother, 52, 10: 3701-3709.pl
    dc.description.referencesSanglard D., Ischer F., Parkinson T., Falconer D., Bille J. (2003) Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents. Antimicrob Agents Chemother, 478: 2404-2412.pl
    dc.description.referencesGeraghty P., Kavanagh K. (2003) Disruption of mitochondrial function in Candida albicans leads to reduced cellular ergosterol levels and elevated growth in the presence of amphotericin B. Archives of microbiology, 179,4: 295-300.pl
    dc.description.referencesMesa-Arango A. C., Scorzoni L., Zaragoza O. (2012) It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug. Fronties in Microbiology, 3: 1-10.pl
    dc.description.referencesPerlin D. S., Shor E., Zhao Y. (2015) Update on Antifungal Drug Resistance. Current Clinical Microbiology Reports, 2: 84-95.pl
    dc.description.referencesSilva S., Rodrigues C. F., Araujo D., Rodrigues M. E., Henriques M. (2017) Candida Species Biofilms' Antifungal Resistance. Journal of Fungi, 3, 1: 1-17.pl
    dc.description.referencesTaff H.T., Mitchell K.F., Edward J. A., Andes D.R. (2013) Mechanisms of Candida biofilm drug resistance. Future Microbiology, 8, 10: 1325-1337.pl
    dc.description.referencesVandeputte P., Ferrari S., Coste A.T. (2012) Antifungal Resistance and New Strategies to Control Fungal Infections. International Journal of Microbiology, Article ID 713687.pl
    dc.description.referencesNett J. E., Crawford K, Marchillo K., Andes D. R (2010) Role of Fks1p and Matrix Glucan in Candida albicans Biofilm Resistance to an Echinocandin, Pyrimidine, and Polyene. Antimicrobial agents and chemotherapy, 54, 8: 3505-3508.pl
    dc.description.referencesRamage G., Rajendran R., Sherry L., Williams C. (2012) Fungal biofilm resistance. International Journal of Microbiology, 2012, 528521.pl
    dc.description.referencesBojsen R., Regenberd B., Gresham D., Flokesson A. (2016) A common mechanism involving the TORC1 pathway can lead to amphotericin B-persistence in biofilm and planktonic Saccharomyces cerevisiae populations. Scientific Reports, 6: 21874pl
    dc.description.referencesTaff H. T., Mitchell K.E., Edward J. A., Andes D. R. (2013) Mechanism of Candida biofilmu drug resistance, Future Microbiology, 8, 10: 1-19.pl
    dc.description.referencesWuyts J., van Dijck P., Holtappels M. (2018) Fungal persister cells: the basis for recalcitrant infections? PLoS Pathog, 14, 10: e1007301.pl
    dc.description.referencesRodrigues C. E., Ridrigues M. E., Silva S., Henriques M. (2017) Candida glabrata Biofilms: How Far Have We Come? Journal of Fungi, 3, 1: 11.pl
    dc.description.referencesBaillie G. S., Douglas L.J. (1998) Effect of growth rate on resistance of Candida albicans biofilms to antifungal drugs. Antimicrobial Agents and Chemotherapy, 42:1900-1905.pl
    dc.description.referencesLinares C. E., Giacomelli S. R., Altenhofen D., Alves S. H., Morsch V. M., Schetinger M. R. (2013) Fluconazole and amphotericin-B resistance are associated with increased catalase and superoxide dismutase activity in Candida albicans and Candida dubliniensis. Revista da Sociedade Brasileira de Medicina Tropical, 46, 6: 752-758.pl
    dc.description.referencesYu L., Zhang W., Wang L. et al. (2007) Transcriptional Profiles of the Response to Ketoconazole and Amphotericin B in Trichophyton rubrum. 51, 1: 144-153.pl
    dc.description.referencesBahmed K., Bonaly R., Coulon J. (2003) Relation between celI wall chitin content and susceptibility to amphotericin B in Kluyveromyces, Candida and Schizosaccharomyces species. Research in Microbiology, 154, 3: 215-222.pl
    dc.description.referencesBahmed K., Bonaly R., Wathier M., Pucci B., Coulon J. (2002) Change of celI wall chitin content in amphotericin B resistant Kluyveromyces strains. FEMS Microbiology Letters, 216, 1: 99-103pl
    dc.description.referencesSeo K., Akiyoshi H., Ohnishi Y. (1999) Alteration of celI wall composition leads to amphotericin B resistance in Aspergillus flavus. Microbiology and immunology, 43, 11: 1017-1025.pl
    dc.description.referencesShishodia S. K., Tiwari S., Shankar J. (2019) Resistance mechanism and proteins in Aspergillus species against antifungal agents. Mycology, 10, 3: 151-165.pl
    dc.description.firstpage146pl
    dc.description.lastpage156pl
    dc.identifier.citation2Modern problems and solutions in environmental protection. Post-conference monograph of Current Environmental Issues 2019, edited by by Joanna Karpińska, Marek Bartoszewicz, Róża Sawczukpl
    dc.conferenceXIV Międzynarodowa Interdyscyplinarna Konferencja "Current Environmental Issues-2019", 24-26 września 2019 r.pl
    Występuje w kolekcji(ach):Książki / Rozdziały (WUwB)
    Materiały konferencyjne (WBiol)
    XIV Międzynarodowa Interdyscyplinarna Konferencja "Current Environmental Issues-2019", 24-26 września 2019

    Pliki w tej pozycji:
    Plik Opis RozmiarFormat 
    M_Siemieniuk_E_Grabowska_U_Czyzewska_M_Bartoszewicz_A_Tylicki_Polyenes_in_therapy_of_mycosis.pdf519,51 kBAdobe PDFOtwórz
    Pokaż uproszczony widok rekordu Zobacz statystyki


    Pozycja jest chroniona prawem autorskim (Copyright © Wszelkie prawa zastrzeżone)